Form 8-K - Current report:
SEC Accession No. 0001193125-26-073439
Filing Date
2026-02-26
Accepted
2026-02-26 07:38:33
Documents
12
Period of Report
2026-02-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lnth-20260226.htm   iXBRL 8-K 46766
2 EX-99.1 lnth-ex99_1.htm EX-99.1 829372
3 GRAPHIC img66337839_0.jpg GRAPHIC 19366
  Complete submission text file 0001193125-26-073439.txt   1046650

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lnth-20260226.xsd EX-101.SCH 26007
14 EXTRACTED XBRL INSTANCE DOCUMENT lnth-20260226_htm.xml XML 4941
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36569 | Film No.: 26681735
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)